Replies to post #76279 on Biotech Values

[DewDiligence]

Webcast Calendar

[Please see updating procedure at
the end of this post. All times are
U.S. ET unless indicated otherwise.]

NOTE: ANYONE MAY UPDATE THIS FILE


Edits: Added INFORM-1 webcast from EASL.


HCV presentations from EASL:

• VRTX/JNJ – Telaprevir/PROVE-3 presentation from EASL:
Sat 4/25/09 1pm ET (http://investors.vrtx.com/events.cfm )

• Roche/ITMN/VRUS – INFORM-1 presentation from EASL:
Sat 4/25/09 1pm ET (www.intermune.com or www.pharmasset.com)


Deutsche Bank Securities 34th Annual Health Care Conference
Boston, MA
May 18-19, 2009
http://conferences.db.com/americas/healthcare09/ (schedule not yet posted)

Goldman Sachs Healthcare Conference
June 9 2009

Morgan Stanley Global Healthcare Conference
September 14 - 15 2009

Merrill Lynch Pharma Conference
September 15 - 17 2009

UBS Global Life Science Conference
September 21, 2009

--
Procedure for Updating Calendar

When adding or modifying entries, please follow these steps:

1. Copy the complete text from the old calendar.

2. Make your additions or modifications, inserting new items in alphabetical or chronological order as the case may be.

3. Near the top of the message, give a very brief description of your changes (e.g. “Edits: Added JPMorgan conference”).

4. Post the updated calendar in a new message as a reply to the message with the old calendar.

[ghmm]

INFORM:

Per the Pharmasset call yesterday (didn't catch all of it yet) they indicated that Roche confirmed will have some data from the low/high high/low cohort as well as the "high/high" 200mg q8 191 and 1000mg 7128.
http://investor.pharmasset.com/events.cfm